Conversely, AhR activation by the potent agonists TCDD and DMBA was found to increase the breast cancer stem cell population and was implicated in doxorubicin resistance of MCF-7 breast cancer cells (Al-Dhfyan et al., 2017). This evidence concerns the gene AHR and breast cancer.